Qualitek Labs Schedules Board Meeting on May 15, 2026 to Approve FY26 Audited Financial Results
Qualitek Labs has scheduled a Board of Directors meeting on May 15, 2026, to consider and approve audited standalone and consolidated financial results for the half year and financial year ended March 31, 2026. The meeting has been intimated to the Bombay Stock Exchange pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015. The trading window for designated and connected persons has been closed since April 01, 2026, and will reopen 48 hours after the financial results are publicly disclosed.

*this image is generated using AI for illustrative purposes only.
Qualitek Labs has notified the Bombay Stock Exchange of an upcoming Board of Directors meeting scheduled for Friday, May 15, 2026. The intimation was filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated via a letter dated May 12, 2026, signed by Company Secretary and Compliance Officer Mohit Kumar.
Board Meeting Agenda
The board meeting has been convened to address key financial and administrative matters. The following table outlines the primary agenda items:
| Agenda Item: | Details |
|---|---|
| Meeting Date: | Friday, May 15, 2026 |
| Financial Results: | Audited Standalone and Consolidated Financial Results |
| Period Under Review: | Half year and financial year ended March 31, 2026 |
| Auditor's Report: | To be considered as per Regulation 33 of SEBI (LODR) Regulations, 2015 |
| Other Business: | Any other business with permission of the Chair |
The board will consider and approve the audited financial results for both standalone and consolidated entities, along with the Auditor's Report prepared by the Statutory Auditor of the Company.
Trading Window Closure
In compliance with the Company's Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of Qualitek Labs has been closed for Designated Person(s), Connected Person(s), and their immediate relative(s). Key details of the trading window restriction are as follows:
- Closure effective from: April 01, 2026
- Basis for closure: Communication letter dated March 27, 2026
- Reopening: 48 hours after the audited standalone and consolidated financial results are made generally available to the public
Regulatory Compliance
The intimation has been filed in accordance with the applicable SEBI listing regulations. Qualitek Labs has stated that the aforesaid information will also be made available on the Company's official website at https://www.qualiteklab.com . The filing was digitally signed by Mohit Kumar, Company Secretary cum Compliance Officer (ACS 38142), on May 12, 2026.
Historical Stock Returns for Qualitek Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.18% | +11.04% | +13.89% | +5.97% | +32.68% | +104.51% |
How have Qualitek Labs' revenue and profitability trends evolved over the financial year ended March 31, 2026, compared to the previous year?
Will the board consider any dividend declaration or capital allocation changes alongside the approval of the FY2026 audited financial results?
Are there any pending regulatory concerns or audit qualifications that could impact investor sentiment following the release of Qualitek Labs' financial results?


































